Oxy-232

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameOxy-232

Drug Alias NameOxy-232

ClassificationSmall molecules

Mechanisms of ActionVirus replication inhibitors

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMAX BioPharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A